Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin

Implication of cancer biology to the future

Evolutionary Biology of Cancer-1

Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene Therapy and Disease Correction

Facilitating Advanced Drug Development and Evaluation Using CRISPR-Cas9 Technology

Bad Luck vs Peto's Paradox in Caner incidences

Experimental design course 041917 (3)